Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06002191 · ClinicalTrials.gov registry record · NA
Development and Testing of imHere4U: A Digital Suicide Prevention Intervention for Cyberbullied Adolescents
A NA study of Suicidal Ideation and Psychological Distress, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06002191 is a NA study of Suicidal Ideation and Psychological Distress that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 80 participants, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06002191, a NA study of Suicidal Ideation and Psychological Distress, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to test the feasibility and preliminary efficacy of Flourish (formerly referred to as imHere4U), a digital suicide prevention intervention for cyberbullied adolescents. The specific aims are to: Aim #1: Conduct a randomized controlled trial (RCT) comparing Flourish+Questionnaires vs. Questionnaires Alone among cyberbullied youth at-risk for suicide ages 12-17 (N=80, \>35% underserved youth). H2a. Primary outcome: Feasibility will be evidenced by recruitment/retention rates \> 80% and imHere4U engagement \> 70%. H2b. Secondary outcomes: Youth assigned to Flourish+Questionnaires will report improved problem-solving capacity, distress tolerance, and motivation and reduced distress and suicidal ideation than youth assigned to Questionnaires Alone over the 6-month follow-up period. Exploratory Aim: Examine the feasibility of delivering feedback on online interactions from machine learning algorithms. All youth assigned to Flourish may optionally provide their social media data to receive feedback from machine learning algorithms. H3a. Feedback from algorithms will have high acceptability (identified via qualitative themes and \>70% acceptance rates) and usability, defined by mean scores on Post-Study System and Usability Questionnaire (PSSUQ) \> 6.
Conditions Studied
Interventions
- BEHAVIORAL Flourish
- BEHAVIORAL Questionnaires of Online Experiences
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-11-21 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06002191
The ClinicalTrials.gov registry entry for NCT06002191 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (70% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 2 interventions - of which Flourish is the first listed.
NCT06002191 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06002191 about?
NCT06002191 is a clinical study titled "Development and Testing of imHere4U: A Digital Suicide Prevention Intervention for Cyberbullied Adolescents". The objective of this study is to test the feasibility and preliminary efficacy of Flourish (formerly referred to as imHere4U), a digital suicide prevention intervention for cyberbullied adolescents. The specific aims are to: Aim #1: Conduct a randomized controlled trial (RCT) comparing Flourish+Q...
What is the current status of trial NCT06002191?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-11-21. Estimated completion is 2026-08.
What conditions does trial NCT06002191 study?
This clinical trial studies the following conditions: Suicidal Ideation, Psychological Distress.
What interventions are being tested in trial NCT06002191?
The interventions under investigation include: Flourish (BEHAVIORAL), Questionnaires of Online Experiences (BEHAVIORAL).
Who is sponsoring clinical trial NCT06002191?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06002191 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.